A computational study on the reduction behavior of iron ore carbon composite pellets in both single and multi-layer bed rotary hearth furnace

A phenomenological model for the reduction of iron ore/carbon composite pellets in a multi-layer bed rotary hearth furnace has been developed. A single pellet model has been scaled up to a multi-pellet layer version in a computationally efficient way. The multi-layer pellet bed has been conceived as single column of identical pellets in a rectangular enclosure, assuming symmetry of the pellet bed in horizontal direction. The column walls are considered opaque with respect to heat transfer but allow heat radiation to reach the pellet surface through multiple reflections from the wall. The time-temperature-transformation and time-temperature-chemical heat absorption contours are presented to provide a better understanding of the reduction process. Finally, the net heat flux and carbon monoxide generation, emerging from the multi-layer bed system has been generated, which may be used as source and sink terms for CFD simulations in the free board of the RHF

Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease

BACKGROUND: Patients with atherosclerotic vascular disease remain at high risk for cardiovascular events despite effective statin-based treatment of low-density lipoprotein (LDL) cholesterol levels. The inhibition of cholesteryl ester transfer protein (CETP) by anacetrapib reduces LDL cholesterol levels and increases high-density lipoprotein (HDL) cholesterol levels. However, trials of other CETP inhibitors have shown neutral or adverse effects on cardiovascular outcomes. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving 30,449 adults with atherosclerotic vascular disease who were receiving intensive atorvastatin therapy and who had a mean LDL cholesterol level of 61 mg per deciliter (1.58 mmol per liter), a mean non-HDL cholesterol level of 92 mg per deciliter (2.38 mmol per liter), and a mean HDL cholesterol level of 40 mg per deciliter (1.03 mmol per liter). The patients were assigned to receive either 100 mg of anacetrapib once daily (15,225 patients) or matching placebo (15,224 patients). The primary outcome was the first major coronary event, a composite of coronary death, myocardial infarction, or coronary revascularization. RESULTS: During the median follow-up period of 4.1 years, the primary outcome occurred in significantly fewer patients in the anacetrapib group than in the placebo group (1640 of 15,225 patients [10.8%] vs. 1803 of 15,224 patients [11.8%]; rate ratio, 0.91; 95% confidence interval, 0.85 to 0.97; P=0.004). The relative difference in risk was similar across multiple prespecified subgroups. At the trial midpoint, the mean level of HDL cholesterol was higher by 43 mg per deciliter (1.12 mmol per liter) in the anacetrapib group than in the placebo group (a relative difference of 104%), and the mean level of non-HDL cholesterol was lower by 17 mg per deciliter (0.44 mmol per liter), a relative difference of -18%. There were no significant between-group differences in the risk of death, cancer, or other serious adverse events. CONCLUSIONS: Among patients with atherosclerotic vascular disease who were receiving intensive statin therapy, the use of anacetrapib resulted in a lower incidence of major coronary events than the use of placebo. (Funded by Merck and others; Current Controlled Trials number, ISRCTN48678192 ; ClinicalTrials.gov number, NCT01252953 ; and EudraCT number, 2010-023467-18 .)

Modification of oxide inclusions in calcium-treated Al-killed high sulphur steels

A study has been carried out to understand the modification of alumina inclusions in Al-killed high sulphur steel with calcium treatment. For calcium treatment to be effective, a general practice is to desulphurise the steel to prevent the formation of solid CaS inclusions that are harmful to steel quality and final properties. To avoid this additional desulphurising step, the authors developed a new approach of calcium treatment of steel at an industrial scale. This approach involves treating the liquid steel with calcium treatment at low aluminium levels which enables formation of liquid calcium aluminate inclusions (C12A7) in the melt and then adding remaining amount of required aluminium. Based on this principle, Al-S diagram has been developed and calcium treatment has been modified accordingly. The inclusion transformation and morphology were studied using scanning electron microscope /energy dispersive spectroscopy analysis and. activity of CaS was calculated

Green Synthesis of Nanoparticles and Their Application in Cancer Therapy

none6simixedValeria De Matteis; Mariafrancesca Cascione; Loris Rizzello; Eva Liatsi-Douvitsa; Azzurra Apriceno; Rosaria RinaldiDE MATTEIS, Valeria; Cascione, Mariafrancesca; Rizzello, Loris; Liatsi-Douvitsa, Eva; Apriceno, Azzurra; Rinaldi, Rosari